Covid-19 Transmission, Risks Factors and Disease Characteristics in Asthmatics Patients
04. Okt. 2022
Über diesen Artikel
Online veröffentlicht: 04. Okt. 2022
Seitenbereich: 125 - 132
Eingereicht: 01. Mai 2022
Akzeptiert: 01. Juli 2022
DOI: https://doi.org/10.2478/am-2022-011
Schlüsselwörter
© 2022 Shatha A. Alduraywish, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Historical data on Coronavirus epidemiology and transmission [71, 72]
| Coronavirus | Affected host | Intermediate host | Potential reservoir host | Disease | Cell receptor | |
|---|---|---|---|---|---|---|
| SARS-CoV | Humans | Himalayan palm civet/raccoon | Bat | SARS | ACE2 | |
| MERS-CoV | Humans | Dromedary camels | Bat | MERS | DPP4 (Dipeptidyl peptidase 4) | |
| SARS-CoV-2 | Humans | NA (No report) | NA (No report) | COVID-19 | ACE2 | |
Common reported symptoms of COVID-19
| Study | Chen N. |
Huang C. |
Alsofayan Y.M. |
Shabrawishi M. |
|---|---|---|---|---|
| Patient count | 99 | 41 | 1519 | 150 |
| Age (mean, year) | 55.5 | 49 | 37 | 46.1 |
| Fever | 83% | 98% | 86% | 49% |
| Cough | 82% | 76% | 89% | 49% |
| Shortness of breath | 31% | 55% | – | 20% |
| Myalgia | 11% | 44% | 29% | 3% |
| Hemoptysis | – | 5% | – | 0.4% |
| Sputum production | – | 28% | – | 3% |
| Confusion | 9% | – | – | – |
| Sore throat | 5% | – | 82% | 16% |
| Rhinorrhea | 4% | – | 72% | 6% |
| Chest pain | 2% | – | – | – |
| Diarrhea | – | 3% | 14% | 1% |
| Headache | – | 8% | 27% | 3% |